Skip to content

Analysis of response and influencing factors of targeted therapy for refractory urticaria

Analysis of response and influencing factors of targeted therapy for refractory urticaria

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098050
Enrollment
Unknown
Registered
2025-02-28
Start date
2024-12-12
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urticaria

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of Army Military Medical University(YNMT)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with urticaria (including acute urticaria, chronic spontaneous urticaria, chronic induced urticaria); (2) Patients with double dose or combined antihistamine treatment is ineffective (acute urticaria for more than 1 week, chronic urticaria for 2 weeks); (3) The patient has a complete treatment process, and the final treatment effect, onset speed and prognosis can be obtained through medical records or follow-up.

Exclusion criteria

Exclusion criteria: 1. Patients with urticaria improved significantly after antihistamine treatment; 2. Patients with major cardiovascular diseases, tumors and other diseases; 3. Incomplete data.

Design outcomes

Primary

MeasureTime frame
Disease activity score in patients with urticaria;Urticaria Control Rating Scale;Immunoglobulin IgE;

Countries

China

Contacts

Public ContactQiquan Chen

The First Affiliated Hospital of Army Military Medical University(YNMT)

chenqq0548@163.com+86 156 8383 4143

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026